Bayer Aktiengesellschaft

Troponwerke Gmbh & Co Kg

Bayer Healthcare Aktiengesellschaft

Aicuris Gmbh + Co. Kg.

Bayeraktiengesellschaft

Siegfried Raddatz

Romanis Fruchtmann

Klaus-Helmut Mohrs

Michael Matzke

Reiner Muller-Peddinghaus

Christian Kohlsdorfer

Armin Hatzelmann

Klaus Mohrs

Rainer Endermann

Stefan Wohlfeil

Ulrich E Muller

Martin Beuck

Joachim Mittendorf

Wolfgang Bender

Frank Mauler

Joachim Schuhmacher

Kerstin Henninger

Siegfried Goldmann

Hilmar Bischoff

Stanislav Kazda

Walter Hubsch

Thomas Lampe

Gunter Schmidt

Jörg Keldenich

Rudolf H Hanko

Dirk Denzer

Matthias Muller-Gliemann

Richard D Connell

Thomas Kramer

Tobias Wunberg

Arnold Paessens

Jurgen Dressel

Joerg Keldenich

Ulrich Niewohner

Hanno Wild

Holger Zimmermann

Rudi Grutzmann

Eugen Etschenberg

Stefan Weigand

Jutta Hansen

Elisabeth Perzborn

Mazen Es-Sayed

Thomas Glaser

Hans-Georg Heine

Harald Horstmann

Jorg Traber

Dieter Habich

Markus Kordes

Peter-Rudolf Seidel

Yolanda Cancho Grande

Pia Theisen-Popp

J&ouml;rg Keldenich

Verena V&ouml;hringer

Arno Friedl

Reinhard Jork

Peter Spreyer

J&uuml;rgen Franz

J&uuml;rgen Dressel

Michael-Harold Rock

Martin Michels

Wolfgang Opitz

Peter Eckenberg

Ervin Horv&aacute;th

Martin Radtke

Armin Kern

Jürgen Reefschläger

Jean Marie Viktor De Vry

Matthias Decker

Yolanda Cancho-Grande

Sabine Hallenberger

Joachim Schumacher

Ervin Horv&agrave;th

Kerstin Ehlert

Franz Zumpe

Jean-Marie-Victor De Vry

Rudolf Sundermann

Holger Paulsen

Christoph Freiberg

Hein-Peter Kroll

Karl-Heinz Boltze

Friedrich Hoffmeister

Mithat Mardin

Armin De Meijere

Burkhard Fugmann

Bernhard Pelster

Isabelle Adelt

Wolf-Dieter Busse

Andreas Schumacher

Wolfgang Roben

Berthold Hinzen

Dieter H Abich

Wolfgang R Oben

Joachim Kr&uuml;ger

Dieter H&auml;bich

Michael Brands

Frank-Ulrich Geschke

Vladimir N Belov

Victor Sokolov

Sergej Kozhushkov

The invention relates to antibacterial macrocycles with substituted biphenyl and processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially of bacterial infections.

Antibacterial macrocycles with substituted biphenyl

The invention relates to antibacterial amide macrocycles and processes for their preparation, their use for the treatment and/or prophylaxis of diseases and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially bacterial infections.

Antibacterial amide macrocycles IV

The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions comprising them, and their use in the treatment of diseases in humans or animals. 

Antibacterial macrocycles

The present invention relates to novel sulphonamides of the general formula (I) in which the substituents R, R, R, Rand A and X are as defined in claimand other claims, and also to processes for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses.

Arylsulfonamides as antiviral agents

The invention relates to novel sulfonamides of general formula (I) where the substituents R, R, R, R, A and X have the given meanings, pharmaceutical compositions containing them, and a method of using them as antiviral agents, in particular against cytomegaloviruses.

Hetrocyclic aryl sulphonamides

The present invention relates to novel arylsulphonamides and analogues, to processes for their preparation and to their use for the prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy, craniocerebral trauma, pain and spasticity.

Arylsulphonamides and analogues

Tan-1057 derivatives

The present invention relates to new aryl ether sulphonamides and analogues, processes for their preparation and their use for the treatment of neurodegenerative disorders, in particular for the prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy and craniocerebral trauma.

Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases

Aryl sulphonamides and analogues

The present invention relates to new aryl ether sulphonamides and analogs, processes for their preparation and their use for the treatment of neurodegenerative disorders, in particular for the prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy and craniocerebral trauma.

The invention relates to phenylacetic acid derivatives which are substituted by a five-membered nitrogen heterocycle bonded via an N atom. They are prepared by reaction of phenylacetic acid derivatives substituted with leaving groups with the appropriate nitrogen heterocycles and can be used as active substances in medicaments for the treatment of high blood pressure and atherosclerosis.

Heterocyclically substituted phenylacetic acid derivatives and their use

Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents are prepared by reaction of the corresponding oxyphenylcarboxylic acids with heterocyclic substituents with phenylglycinol. The new substances are suitable as active compounds in medicaments, in particular in agents having an antiatherosclerotic action.

Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents

Oxy-phenyl-(phenyl)gycinolamides with heterocyclic substituents are prepared by reaction of the corresponding oxyphenylcarboxylic acids with heterocyclic substituents with phenylglycinol. The new substances are suitable as active compounds in medicaments, in particular in agents having an antiatherosclerotic action.

Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives are prepared by reacting correspondingly substituted phenols with quinolylmethyl halides or by reacting unsubstituted phenols with quinolylmethyl halides and subsequent alkylation. The substituted quinol-2-yl-methoxy-phenylacetic acid derivatives may be employed as active substances in medicaments.

Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives

The present invention relates to substituted (2-oxo-1-benzimidazolinyl)-piperidines of the general formula (I) ##STR1## in which the substituents have the meaning indicated in the description, to processes for their preparation and to their use as antiretroviral agents.

Substituted (2-oxo-1-benzimidazolinyl)-peperidines, process for their

Growing community of inventors

Cologne, Germany

Siegfried Raddatz